MedTrace Logo

Feasibility Pilot of Bright Light in the Intensive Care Unit

NCT03568045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-06-17

Study results available
· View outcomes & findings →

Summary

To evaluate the feasibility of providing daytime bright light in the ICU in a pilot randomized controlled trial.

Conditions

  • Circadian Rhythm Sleep Disorder, Unspecified

Interventions

DEVICE

standard light

usual care

DEVICE

10,000 lux bright light, 4 hours

Bright light will be delivered by a free-standing 10,000 lux device that will be positioned next to the patient's head of bed. At the estimated distance of 36 inches from light source to the patient, we anticipate approximately a 1,250 lux dose at the patient's eye. Light will be delivered from 8am to noon.

DEVICE

10,000 lux bright light, 8 hours

Bright light will be delivered by a free-standing 10,000 lux device that will be positioned next to the patient's head of bed. At the estimated distance of 36 inches from light source to the patient, we anticipate approximately a 1,250 lux dose at the patient's eye. Light will be delivered from 8am to 4pm.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Melissa Knauert, MD, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2023-03-31
Completion
2024-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03568045 on ClinicalTrials.gov